Abeona Therapeutics Inc (ABEO.OQ)
ABEO.OQ on NASDAQ Stock Exchange Capital Market
8.12USD
5:05pm BST
8.12USD
5:05pm BST
Change (% chg)
$0.13 (+1.63%)
$0.13 (+1.63%)
Prev Close
$7.99
$7.99
Open
$8.02
$8.02
Day's High
$8.19
$8.19
Day's Low
$7.85
$7.85
Volume
53,904
53,904
Avg. Vol
163,324
163,324
52-wk High
$22.00
$22.00
52-wk Low
$6.28
$6.28
About
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin... (more)
Overall
| Beta: | 1.92 |
| Market Cap(Mil.): | $384.26 |
| Shares Outstanding(Mil.): | 48.09 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ABEO.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 110.59 | 62.94 |
| EPS (TTM): | -1.19 | -- | -- |
| ROI: | -34.64 | 8.01 | 11.75 |
| ROE: | -37.27 | 8.19 | 12.58 |
Estimates